These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20512539)

  • 41. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Special considerations for antihypertensive agents in dialysis patients.
    Redon J; Martinez F; Cheung AK
    Blood Purif; 2010; 29(2):93-8. PubMed ID: 20093810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
    Onuigbo MA
    Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
    [No Abstract]   [Full Text] [Related]  

  • 44. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2003; 119(16):1505-7. PubMed ID: 14535023
    [No Abstract]   [Full Text] [Related]  

  • 47. [Renal effects of combined anti-hypertensive treatments].
    Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D
    Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin-angiotensin system modulation: the weight of evidence.
    Brown B; Hall AS
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
    Coats AJ
    Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
    Andraws R; Brown DL
    Am J Cardiol; 2007 Apr; 99(7):1006-12. PubMed ID: 17398202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice.
    Pitt B
    Heart; 2009 Aug; 95(15):1205-8. PubMed ID: 19401281
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
    Greenwood V
    J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.
    Vistisen ST; Bodilsen J; Scheeren TWL; Simonsen U
    Eur J Anaesthesiol; 2020 Sep; 37(9):739-742. PubMed ID: 32769503
    [No Abstract]   [Full Text] [Related]  

  • 58. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 59. Renin-angiotensin system and cardiovascular risk.
    Strauss MH; Hall A
    Lancet; 2007 Jul; 370(9581):23-4; author reply 24-5. PubMed ID: 17617258
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
    Rosenborg S
    Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.